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Abstract
BACKGROUND AND PURPOSE—Delayed cerebral ischemia is a significant cause of
morbidity and mortality after aneurysmal SAH, leading to poor outcomes. The purpose of this
study was to evaluate the usefulness of CTP in determining delayed cerebral ischemia in patients
with aneurysmal SAH.
MATERIALS AND METHODS—We conducted a systematic review evaluating studies that
assessed CTP in patients with aneurysmal SAH for determining delayed cerebral ischemia. Studies
using any of the following definitions of delayed cerebral ischemia were included in the
systematic review: 1) new onset of clinical deterioration, 2) cerebral infarction identified on
follow-up CT or MR imaging, and 3) functional disability. A random-effects meta-analysis was
performed assessing the strength of association between a positive CTP result and delayed
cerebral ischemia.
RESULTS—The systematic review identified 218 studies that met our screening criteria, of
which 6 cohort studies met the inclusion criteria. These studies encompassed a total of 345
patients, with 155 (45%) of 345 patients classified as having delayed cerebral ischemia and 190
(55%) of 345 patients as not having delayed cerebral ischemia. Admission disease severity was
comparable across all groups. Four cohort studies reported CTP test characteristics amenable to
the meta-analysis. The weighted averages and ranges of the pooled sensitivity and specificity of
CTP in the determination of delayed cerebral ischemia were 0.84 (0.7–0.95) and 0.77 (0.66–0.82),
respectively. The pooled odds ratio of 23.14 (95% CI, 5.87–91.19) indicates that patients with
aneurysmal SAH with positive CTP test results were approximately 23 times more likely to
experience delayed cerebral ischemia compared with patients with negative CTP test results.
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CONCLUSIONS—Perfusion deficits on CTP are a significant finding in determining delayed
cerebral ischemia in aneurysmal SAH. This may be helpful in identifying patients with delayed
cerebral ischemia before development of infarction and neurologic deficits.
Aneurysmal SAH is a devastating condition that occurs in up to 30,000 people in the United
States annually and carries a 51% case mortality.1,2 Delayed cerebral ischemia (DCI) is
considered the most significant cause of morbidity and mortality in patients who survive the
initial hemorrhage, with poor outcomes occurring in up to 30% despite aggressive
therapy.3,4 The definition of DCI is variable and has been described as a new onset of
clinical deterioration, not explained by other causes.5 However, recently it has been
recommended to define DCI on the basis of its primary outcome measures, such as cerebral
infarction and functional disability.6 Therefore, DCI is a challenging diagnosis to make
prospectively, before its poor outcomes, particularly in comatose or sedated patients, thus
limiting initiation of pre-emptive therapy.5 Despite these difficulties, DCI is used to
complement older clinicoradiographic terminology such as angiographic vasospasm and
symptomatic vasospasm because DCI has been shown to have the strongest associations
with poor outcomes, including cognitive impairment and reduced quality of life after
aneurysmal SAH.6 Furthermore, it has become clear that the pathogenesis of DCI is not
fully attributable to large-vessel vasospasm alone and may, in fact, be the result of several
independent processes acting in concert.7 The common denominator, however, seems to be
hemodynamic alterations in cerebral perfusion leading to ischemia and/or infarction.
Cerebral perfusion can be assessed by use of CT, MR, PET, and SPECT imaging.
Specifically, CTP is a technique that allows for rapid, noninvasive assessment of CBF,
MTT, and CBV. CTP has had an increasing role in the evaluation of patients with
aneurysmal SAH, as it can be performed in conjunction with traditional noncontrast CT and
CTA, requiring little extra examination time.8 Many initial studies have evaluated the
diagnostic accuracy of CTP for vasospasm compared with DSA- and CTA-defined
vasospasm. However, CTP remains a relatively new technique for the evaluation of DCI,
and it remains unclear how well CTP can detect DCI.9 Given the limitations of relying on
the conclusions of individual studies in the literature, particularly when relatively small
cohorts are used and findings are not entirely conclusive, we aimed to perform a systematic
review and meta-analysis to evaluate CTP in the detection of DCI in patients with
aneurysmal SAH.
MATERIALS AND METHODS
We have implemented the methods described in the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses statement.10
Eligibility Criteria
To be more inclusive in identifying studies in the literature that evaluated CTP for DCI in
patients with aneurysmal SAH, we included any of the following definitions of DCI in our
inclusion criteria: 1) clinical deterioration not explained by other causes and sufficiently
judged to be the result of DCI, 2) cerebral infarction identified on follow-up CT or MR
imaging, and 3) functional disability related to DCI. If any one of these criteria was positive,
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DCI was considered to have occurred. We limited our selection to include manuscripts
published in English only. In cases of duplicated cohorts, we included the study with the
largest number of patients.
Information Sources and Search
An experienced medical librarian performed a systematic search to identify studies in
accordance with the eligibility criteria. Potential articles were found by a search of the
electronic data bases of Ovid MEDLINE, EMBASE, and Web of Knowledge. Additional
records were identified by use of the Related Articles feature in PubMed and the Cited
Reference Search in the ISI Web of Science. All studies included in these data bases through
March 2013 were searched. Further details of the search strategy are described in the On-
line Appendix.
Study Selection and Data Collection Process
After removal of duplicate articles, search results were preliminarily screened via title and
abstract information by a single reader. Shortlisted manuscripts were independently
reviewed in full by 2 additional readers to determine conformity to the eligibility criteria.
Disagreements were resolved by consensus.
With use of a standardized data collection template, study characteristics including baseline
patient demographics, CTP test characteristics, and detailed DCI outcome data were
collected by 2 independent readers, with disagreements resolved by a third reader. All
eligible studies were included in the qualitative systematic review. Of these, studies
reporting test characteristics or data from which they could be tabulated were included in the
meta-analysis.
Validity Assessment
To assess the validity of each study, we implemented the Quality Assessment of Diagnostic
Accuracy Studies (QUADAS) tool.11 This tool assesses bias in each study according to 14
criteria, with possible answers as “Yes,” “No,” or “Unknown.” Two reviewers scored each
study with disagreements resolved by consensus. The full QUADAS tool is available in the
On-line Appendix.
Statistical Analysis
A meta-analysis was performed on those studies in which test characteristics could be
extracted and/or tabulated. Pooled sensitivity, specificity, and odds ratios with
corresponding 95% CIs were calculated. The pooled sensitivity and specificity were
calculated by use of weighted averages derived from the sample size of each study. The
pooled odds ratio was calculated by use of a random-effects model. We chose this statistical
method rather than the less conservative fixed-effects model because of the wide variation in
these studies, including the definitions of DCI, different CTP protocols, and postprocessing
software, as well as differences in what constituted an abnormal CTP result. Furthermore,
study heterogeneity was assessed by calculating the I2 statistic. All analyses were conducted
by using StataVersion 12 software (StataCorp, College Station, Texas).
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RESULTS
Study Selection
After removal of duplicated citations, search results yielded 218 manuscripts. Of these, 25
articles were selected for full review on the basis of screening the titles and abstracts, with
14 meeting the eligibility criteria. Seventy-one percent (10/14) of these studies were
suspected to contain at least partially overlapping cohorts; therefore, their authors were
contacted for further clarification.12–21 One group replied to our request (authors
of14,16,20,21) and indicated that duplicate cohorts were used; in this case, the study with the
largest number of included patients was included in our review.14 No reply was received
from the other groups; therefore, only those with the largest cohorts were included.12,13 One
study was also excluded for not providing the number of patients in the DCI and non-DCI
groups.22 Finally, 6 studies were included in the systematic review.12–14,23–25 The study
selection is summarized in Fig 1.
Qualitative Assessment and Study Characteristics
The 6 studies that met our final eligibility criteria were all prospective, with 3 completed in
the United States,14,23,24 2 in the Netherlands,12,13 and 1 study in Germany.25 Together,
these studies encompassed 345 patients, of which 155 (45%) were classified as having DCI
and 190 (55%) as not having DCI. Although admission disease severity, demographics, and
median day of DCI onset were comparable across groups, large differences existed in the
cohort sizes with a range from 10 –97 patients (On-line Table 1). Studies tended to
implement CTP imaging either at the onset of symptomatic vasospasm or before; however,
for 2 studies this information was not reported.12,24 Studies had variable CTP methodology
and postprocessing algorithms, variation in the definition of a positive CTP test result, and
variability in the definition of DCI used as an outcome measure (On-line Table 2).
Validity Assessment
The percentage of studies scoring “Yes,” “No,” or “Unknown” for each of the 14 items on
the QUADAS tool is displayed in Fig 2. All of the studies scored “Yes” on items 1 and 8 of
the QUADAS tool, indicating an absence of spectrum bias (presence of a cohort
representative of patients who would receive the index test in practice) and the presence of a
clear description of the definition of DCI. In addition, 80% of studies scored “Yes” on items
2, 3, 5–7, 9, and 12 on the QUADAS tool, indicating that a clear description of selection
criteria was provided; appropriate reference standards were chosen; and that there was an
absence of primary selection bias (whole or part of the study population received
verification by the reference standard), differential verification bias (study population
received verification by the same reference standard), and incorporation bias (the reference
standard was independent of the index test) among most studies. Last, most studies scored
“No” or “Unknown” on items 4, 11, 13, and 14, indicating the presence of disease
progression bias (unsure if the time between implementation of the reference standard and
the index test is short enough to ensure that the target condition did not change between the
2 tests), test classification bias (the reference standard results were interpreted without
knowledge of the results of the index test and vice versa), and a lack of explanation for
patient withdrawals.
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Statistical Analysis
In 4 (67%) of the 6 studies, CTP test characteristics and DCI were reported in a way that
could be tabulated for a meta-analysis.13,14,23,25 This number included studies attempting to
determine optimal CTP characteristics and thresholds to detect DCI; in these cases, we used
the best single test characteristic to tabulate the odds ratio for the meta-analysis (On-line
Table 2). The weighted averages and ranges of the extracted/tabulated sensitivities and
specificities with corresponding ranges of CTP in the detection of DCI from these studies
were 0.84 (0.7– 0.95) and 0.77 (0.66 – 0.82), respectively. The meta-analysis also revealed a
pooled odds ratio of 23.14 (95% CI, 5.87 – 91.19) (Fig 3), suggesting that the patients with
aneurysmal SAH with a positive CTP test were approximately 23 times more likely to
experience DCI compared with those patients with aneurysmal SAH without a positive CTP
test. The study heterogeneity (I2 = 6.96) in these data was not significant (P = .073).
DISCUSSION
The pathogenesis of DCI is now thought to be multifactorial, with an alteration of cerebral
perfusion and reduced CBF leading to ischemia and/or infarction.7 CTP can noninvasively
evaluate cerebral perfusion and can often be combined with other CT-based examinations,
thereby minimizing examination time. Few studies, however, have assessed the ability of
CTP to detect DCI.9
DCI is considered a diagnosis of exclusion and is often difficult to make prospectively,
especially in sedated and/or comatose patients, as physical examinations may not be
reliable.5 Furthermore, defining DCI by its primary outcomes measures only allows its
detection after irreversible damage has already occurred, thus limiting the timely delivery of
efficacious therapy. Because DCI involves perturbations in CBF, it is thought that CTP may
be able to detect DCI before its primary outcomes of cerebral infarction or functional
disability manifest, thus allowing pre-emptive therapy.13
Our systematic review and meta-analysis indicates that patients with aneurysmal SAH with
positive CTP test results demonstrating perfusion deficits are approximately 23-fold more
likely to experience DCI compared with patients with normal CTP results, suggesting that
CTP has the potential to be a useful tool in clinical practice. Compared with other imaging
measures used to detect DCI, such as intraventricular hemorrhage and Fisher scores,
hydrocephalus, and transcranial Doppler flow prolongation, which have reported odds ratios
ranging from 0.5–2.7,26 CTP has demonstrated a higher odds ratio in this meta-analysis.
Moreover, CTP had a superior odds ratio, even at the lower limit of the 95% CI, compared
with other nonimaging-derived parameters, such as an admission mean arterial pressure >
112 mm Hg, which has a reported odds ratio of 3.3.26 This result was achieved despite
variation in the patient populations studied, CTP protocols and software used, and the
various definitions of DCI implemented in the studies included in this meta-analysis.
By applying the QUADAS tool, we found that among the studies included in our systematic
review, most were free of spectrum bias, primary selection bias, differential verification
bias, and incorporation bias (see “Results” section for description). They each also clearly
described the definition of DCI implemented and patient selection criteria used. In most
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cases, the choice of a reference standard was considered appropriate. Most studies, however,
contained signs of disease progression bias and test classification bias (see “Results” section
for description). Last, most studies did not explain patient withdrawals from the study, nor
did they report uninterpretable or intermediate test results. These shortcomings represent
areas of future improvement in diagnostic accuracy studies assessing the role of CTP in
detecting DCI in aneurysmal SAH.
Our analysis also revealed other limitations of the existing literature on CTP for the
detection of DCI. These primarily arose from the nonuniform definitions for DCI used in the
literature, interinstitutional differences in the CTP protocol and postprocessing software
programs used, and the lack of consistency among the definitions of an abnormal CTP test
result (On-line Table 2). Given such variability, our analysis combined the various
definitions of DCI used in each study. Specific subanalyses to determine if a particular
definition of DCI was better detected by CTP could not be performed given the limited
sample size of the studies that met eligibility criteria in this investigation. Other subanalyses
examining the best time to perform CTP to detect DCI (hospital admission, during
symptoms, or both) could also not be performed because of the variability of when CTP was
performed among the studies that met our eligibility criteria. Furthermore, those studies that
assessed CTP test results quantitatively reported test characteristics for different CTP
hemodynamic parameters (MTT, CBF, CBV, and TTP), often by using various thresholds.
In these cases, we chose the CTP parameter and threshold with the greatest overall
diagnostic value for DCI because we were evaluating CTP as a single test and not by its
individual components. These limitations, and the fact that the studies that met our eligibility
criteria also had variable CTP methodology and postprocessing algorithms with evaluation
of the results limited to the anterior circulation, may be sources of bias and must be
considered when the results of our meta-analysis are interpreted. However, despite these
differences among studies, our meta-analysis revealed a statistically significant odds ratio
and no statistically detectable heterogeneity, suggesting that a strong association exists
between CTP deficits and DCI, across variations in DCI definition and CTP technique used.
It is noteworthy to mention that CTP itself has limitations. The amount of brain volume
coverage may be limited in the clinical setting, and the amount of radiation exposure to the
patient is higher compared with standard noncontrast CT of the head.27 Furthermore,
accurate quantification is dependent on an intact blood-brain barrier, which may not be
normally functioning in ischemic events, such as DCI.27 Last, different postprocessing
software vendors may quantify CTP data differently, which may introduce undue variation
in the results. Despite these shortcomings, however, because CTP uses ubiquitous
technology, it has the potential to be quickly and widely implemented. CTP, therefore, may
find a place in the clinical setting for better and earlier detection of DCI and its devastating
outcomes.
CONCLUSIONS
Our meta-analysis revealed a strong association between CTP perfusion deficits and the
development of DCI in patients with aneurysmal SAH. Because DCI is challenging to
diagnose prospectively, treatment is often of limited efficacy when initiated after morbidity
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has already occurred. CTP may aid in the detection of DCI earlier and with more accuracy,
allowing for preemptive therapy and/or closer monitoring to prevent potentially devastating
outcomes of cerebral infarction and functional disability.
Supplementary Material
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Acknowledgments
This publication was supported by Grant Number 5K23NS058387 from the National Institute of Neurological
Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH).
ABBREVIATIONS
DCI delayed cerebral ischemia
QUADAS Quality Assessment of Diagnostic Accuracy Studies
References
1. Graf CJ, Nibbelink DW. Cooperative study of intracranial aneurysms and subarachnoid hemorrhage.
Report on a randomized treatment study. 3. Intracranial surgery. Stroke. 1974; 5:557–601.
[PubMed: 4851187]
2. Hop JW, Rinkel GJ, Algra A, et al. Case-fatality rates and functional outcome after subarachnoid
hemorrhage: a systematic review. Stroke. 1997; 28:660–64. [PubMed: 9056628]
3. Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of
Aneurysm Surgery. Part 1: Overall management results. J Neurosurg. 1990; 73:18–36. [PubMed:
2191090]
4. Mayberg MR. Cerebral vasospasm. Neurosurg Clin N Am. 1998; 9:615–27. [PubMed: 9668192]
5. Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after
aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational
studies: proposal of a multidisciplinary research group. Stroke. 2010; 41:2391–95. [PubMed:
20798370]
6. Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage:
what is the most clinically relevant definition? Stroke. 2009; 40:1963–68. [PubMed: 19359629]
7. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, et al. Cerebral vasospasm: looking beyond
vasoconstriction. Trends Pharmacol Sci. 2007; 28:252–56. [PubMed: 17466386]
8. Hoeffner EG, Case I, Jain R, et al. Cerebral perfusion CT: technique and clinical applications.
Radiology. 2004; 231:632–44. [PubMed: 15118110]
9. Greenberg ED, Gold R, Reichman M, et al. Diagnostic accuracy of CT angiography and CT
perfusion for cerebral vasospasm: a meta-analysis. AJNR Am J Neuroradiol. 2010; 31:1853–60.
[PubMed: 20884748]
10. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
PLoS Med. 2009; 6:e1000100. [PubMed: 19621070]
11. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality
assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res
Methodol. 2003; 3:25. [PubMed: 14606960]
12. van der Schaaf I, Wermer MJ, van der Graaf Y, et al. Prognostic value of cerebral perfusion-
computed tomography in the acute stage after subarachnoid hemorrhage for the development of
delayed cerebral ischemia. Stroke. 2006; 37:409–13. [PubMed: 16373646]
Mir et al. Page 7
AJNR Am J Neuroradiol. Author manuscript; available in PMC 2015 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
13. Dankbaar JW, de Rooij NK, Rijsdijk M, et al. Diagnostic threshold values of cerebral perfusion
measured with computed tomography for delayed cerebral ischemia after aneurysmal
subarachnoid hemorrhage. Stroke. 2010; 41:1927–32. [PubMed: 20689085]
14. Sanelli PC, Ugorec I, Johnson CE, et al. Using quantitative CT perfusion for evaluation of delayed
cerebral ischemia following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol.
2011; 32:2047–53. [PubMed: 21960495]
15. Dankbaar JW, de Rooij NK, Velthuis BK, et al. Diagnosing delayed cerebral ischemia with
different CT modalities in patients with subarachnoid hemorrhage with clinical deterioration.
Stroke. 2009; 40:3493–98. [PubMed: 19762703]
16. Sanelli PC, Anumula N, Johnson CE, et al. Evaluating CT perfusion using outcome measures of
delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol.
2013; 34:292–98. [PubMed: 22859289]
17. van der Schaaf I, Wermer MJ, van der Graaf Y, et al. CT after subarachnoid hemorrhage: relation
of cerebral perfusion to delayed cerebral ischemia. Neurology. 2006; 66:1533–38. [PubMed:
16717213]
18. Dankbaar JW, de Rooij NK, Smit EJ, et al. Changes in cerebral perfusion around the time of
delayed cerebral ischemia in subarachnoid hemorrhage patients. Cerebrovasc Dis. 2011; 32:133–
40. [PubMed: 21778710]
19. Rijsdijk M, van der Schaaf IC, Velthuis BK, et al. Global and focal cerebral perfusion after
aneurysmal subarachnoid hemorrhage in relation with delayed cerebral ischemia. Neuroradiology.
2008; 50:813–20. [PubMed: 18548240]
20. Sanelli PC, Jou A, Gold R, et al. Using CT perfusion during the early baseline period in
aneurysmal subarachnoid hemorrhage to assess for development of vasospasm. Neuroradiology.
2011; 53:425–34. [PubMed: 20694461]
21. Killeen RP, Mushlin AI, Johnson CE, et al. Comparison of CT perfusion and digital subtraction
angiography in the evaluation of delayed cerebral ischemia. Acad Radiol. 2011; 18:1094–100.
[PubMed: 21652232]
22. Lagares A, Cicuendez M, Ramos A, et al. Acute perfusion changes after spontaneous SAH: a
perfusion CT study. Acta Neurochir (Wien). 2012; 154:405–11. discussion 411–12. [PubMed:
22234794]
23. Harrigan MR, Magnano CR, Guterman LR, et al. Computed tomographic perfusion in the
management of aneurysmal subarachnoid hemorrhage: new application of an existent technique.
Neurosurgery. 2005; 56:304–17. [PubMed: 15670379]
24. Sviri GE, Britz GW, Lewis DH, et al. Dynamic perfusion computed tomography in the diagnosis
of cerebral vasospasm. Neurosurgery. 2006; 59:319–25. [PubMed: 16883171]
25. Pham M, Johnson A, Bartsch AJ, et al. CT perfusion predicts secondary cerebral infarction after
aneurysmal subarachnoid hemorrhage. Neurology. 2007; 69:762–65. [PubMed: 17709708]
26. Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of
delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;
32:2012–20. [PubMed: 11546890]
27. Latchaw RE, Yonas H, Hunter GJ, et al. Guidelines and recommendations for perfusion imaging in
cerebral ischemia: A scientific statement for healthcare professionals by the writing group on
perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart
Association. Stroke. 2003; 34:1084–104. [PubMed: 12677088]
28. Reichman MB, Greenberg ED, Gold RL, et al. Developing patient-centered outcome measures for
evaluating vasospasm in aneurysmal subarachnoid hemorrhage. Acad Radiol. 2009; 16:541–45.
[PubMed: 19345894]
29. Reichman M, Gold R, Greenberg E, et al. Validation of a new reference standard for the diagnosis
of vasospasm. Acad Radiol. 2010; 17:1083–89. [PubMed: 20542450]
Mir et al. Page 8
AJNR Am J Neuroradiol. Author manuscript; available in PMC 2015 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIG. 1.
Study selection flow diagram. Figure adapted from the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses Group Statement.10
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FIG. 2.
Percentage of studies included in the systematic review scoring “Yes,” “No,” or “Unknown”
on QUADAS tool criteria. Questions truncated in figure according to information provided
from previously published work.11
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FIG. 3.
Forest plot of data used to tabulate the pooled odds ratios for studies included in the meta-
analysis.
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